364 related articles for article (PubMed ID: 23599360)
1. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
Nissen JL; Skov R; Knudsen JD; Ostergaard C; Schønheyder HC; Frimodt-Møller N; Benfield T
J Antimicrob Chemother; 2013 Aug; 68(8):1894-900. PubMed ID: 23599360
[TBL] [Abstract][Full Text] [Related]
2. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
[TBL] [Abstract][Full Text] [Related]
3. Resurgence of penicillin-susceptible Staphylococcus aureus at a hospital in New York State, USA.
Crane JK
J Antimicrob Chemother; 2014 Jan; 69(1):280-1. PubMed ID: 23925938
[No Abstract] [Full Text] [Related]
4. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study.
Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM
J Antimicrob Chemother; 2015 May; 70(5):1539-46. PubMed ID: 25614044
[TBL] [Abstract][Full Text] [Related]
6. Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Bigseth RS; Sandholdt H; Petersen A; Østergaard C; Benfield T; Thorlacius-Ussing L
Microbiol Spectr; 2022 Jun; 10(3):e0153021. PubMed ID: 35438533
[TBL] [Abstract][Full Text] [Related]
7. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.
Jensen AG; Wachmann CH; Espersen F; Scheibel J; Skinhøj P; Frimodt-Møller N
Arch Intern Med; 2002 Jan; 162(1):25-32. PubMed ID: 11784216
[TBL] [Abstract][Full Text] [Related]
8. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
[TBL] [Abstract][Full Text] [Related]
9. Comparable Effectiveness of First Week Treatment with Anti-Staphylococcal Penicillin versus Cephalosporin in Methicillin-Sensitive Staphylococcus aureus Bacteremia: A Propensity-Score Adjusted Retrospective Study.
Forsblom E; Ruotsalainen E; Järvinen A
PLoS One; 2016; 11(11):e0167112. PubMed ID: 27898714
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus meningitis: experience with cefuroxime treatment during a 16 year period in a Danish region.
Nørgaard M; Gudmundsdottir G; Larsen CS; Schønheyder HC
Scand J Infect Dis; 2003; 35(5):311-4. PubMed ID: 12875516
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort.
Mylotte JM; Tayara A
Clin Infect Dis; 2000 Nov; 31(5):1170-4. PubMed ID: 11073748
[TBL] [Abstract][Full Text] [Related]
12. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
Goldberg E; Paul M; Talker O; Samra Z; Raskin M; Hazzan R; Leibovici L; Bishara J
J Antimicrob Chemother; 2010 Aug; 65(8):1779-83. PubMed ID: 20507860
[TBL] [Abstract][Full Text] [Related]
13. Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology.
Schreiber MP; Chan CM; Shorr AF
J Crit Care; 2011 Aug; 26(4):395-401. PubMed ID: 21036521
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia.
Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Warren SJ; Gao W; Johnson PD; Howden BP
Clin Microbiol Infect; 2013 Dec; 19(12):1163-8. PubMed ID: 23441652
[TBL] [Abstract][Full Text] [Related]
16. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
Davis JS; Turnidge J; Tong S
Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
[TBL] [Abstract][Full Text] [Related]
18. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
Ruotsalainen E; Järvinen A; Koivula I; Kauma H; Rintala E; Lumio J; Kotilainen P; Vaara M; Nikoskelainen J; Valtonen V;
J Intern Med; 2006 Feb; 259(2):179-90. PubMed ID: 16420547
[TBL] [Abstract][Full Text] [Related]
19. Benzylpenicillin versus flucloxacillin for penicillin-susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study.
Henderson A; Harris P; Hartel G; Paterson D; Turnidge J; Davis JS; Tong SYC
Int J Antimicrob Agents; 2019 Oct; 54(4):491-495. PubMed ID: 31181352
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study.
Smit J; López-Cortés LE; Kaasch AJ; Søgaard M; Thomsen RW; Schønheyder HC; Rodríguez-Baño J; Nielsen H
Clin Microbiol Infect; 2017 Jan; 23(1):27-32. PubMed ID: 27343816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
